Oak vs Rehydra+ Wellness
Oak and Rehydra+ Wellness both sell semaglutide and tirzepatide; this is how their prices, coverage and records differ.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Rehydra+ Wellness
Best for: seeing what it charges before you answer any medical questions
Visit Rehydra+ Wellness →If you are choosing between Oak and Rehydra+ Wellness, price alone will not settle it. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. Oak leads our six-part score, 7.8 to 7.1.
Oak vs Rehydra+ Wellness price
Oak and Rehydra+ Wellness start at the same figure, $119 a month, so the entry price does not separate them. Look at what each price covers and at the per-drug prices below.
Drug by drug: Semaglutide costs the same at both, $119 a month; tirzepatide is cheaper at Rehydra+ Wellness ($169 a month vs $185 a month).
Medications and formats
Both sell semaglutide and tirzepatide.
On format they match: each offers compounded injections.
Where each one treats patients
Neither Oak nor Rehydra+ Wellness publishes the states it serves, so enter your state at the very start of each sign-up.
Pricing
Oak
Semaglutide from $119/mo. A '$200 off' new-patient offer is advertised, but its terms and resulting price are not published. Other Oak pages show $133, $167 and $190; $119 is the headline price.
Tirzepatide from $185/mo, with 'One price · All dosages · No subscriptions.' A $200-off new-patient offer is advertised, but how it applies and the final price are not published before the intake questionnaire.
Rehydra+ Wellness
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $119, Tier 2 $169, Tier 3 $229 per month). One-time non-subscription vials start at $149; a separate 2.5 mg listing runs $399-$479.
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $119, Tier 2 $169, Tier 3 $229 per month). One-time non-subscription vials start at $149; a separate 2.5 mg listing runs $399-$479.
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $119, Tier 2 $169, Tier 3 $229 per month). One-time non-subscription vials start at $149; a separate 2.5 mg listing runs $399-$479.
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $169, Tier 2 $289, Tier 3 $419 per month). One-time non-subscription vials start at $219.
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $169, Tier 2 $289, Tier 3 $419 per month). One-time non-subscription vials start at $219.
Recurring monthly price at this rung of Rehydra+'s published dose ladder (Tier 1 $169, Tier 2 $289, Tier 3 $419 per month). One-time non-subscription vials start at $219.
What each price covers
Oak's price also covers the medication itself, shipping and coaching, which Rehydra+ Wellness does not claim.
Oak is silent on the clinician visit and lab work.
Rehydra+ Wellness does not say what its price includes.
That matters most for the drug: unless Rehydra+ Wellness confirms otherwise, budget for medication on top of its listed price.
Oak
Covered by the monthly price
Medication
In the price
Clinician visits
Not stated
Shipping
In the price
Lab work
Not stated
Coaching
In the price
Rehydra+ Wellness
Inclusions not disclosed.
Where each one scores higher
Overall, Oak scores 7.8 and Rehydra+ Wellness 7.1 out of 10.
Oak is stronger on value (8.2 vs 5.7) and support (6.0 vs 5.0).
Effectiveness, user experience, trust & safety and accessibility are within half a point.
Oak
7.8/10
Rehydra+ Wellness
7.1/10
Value25%
Effectiveness25%
User Experience15%
Trust & Safety15%
Accessibility10%
Support10%
FDA warning letters
Neither Oak nor Rehydra+ Wellness has an FDA warning letter on record with us.
Features & Coverage
| Feature | Oak | Rehydra+ Wellness |
|---|---|---|
| Starting Price | $119/mo | $119/mo |
| Features | 4 features | ✓6 features |
| States Available | Not disclosed | Not disclosed |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warning Letters | None | None |
About Oak
Oak sells compounded semaglutide and tirzepatide through telehealth. Oak Longevity Holdings Corp. operates the business, and prescriptions are issued through NVP Medical Group, P.A.
Read our full Oak review →About Rehydra+ Wellness
Dose drives the tier here, so the subscription climbs as you titrate. Paramedics and nurses started the business as mobile IV therapy in San Antonio, Texas, and it now lists compounded semaglutide and tirzepatide beside GHK-Cu, sermorelin, tesamorelin, MOTS-C, KPV and BPC-157, a Lipo-Plus lipotropic shot, NAD+ and testosterone therapy. Consultations cost nothing, the storefront shows its prices, and payment can be financed. The company claims 20 states; the states themselves are never listed.
Read our full Rehydra+ Wellness review →Pros & Cons
Oak
What we like
- Semaglutide costs $119 a month, 36% below the $185 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $185 a month, 26% below the $250 median for compounded tirzepatide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- The monthly price stays the same as your dose goes up
- The monthly price includes the medication, shipping and coaching
- We found no FDA warning letters issued to Oak
Watch-outs
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Rehydra+ Wellness
What we like
- Semaglutide costs $169 a month, close to the $185 median for compounded semaglutide across the sellers we compare
- Shows its price before the medical questionnaire, so you can compare it without handing over health information
- We found no FDA warning letters issued to Rehydra+ Wellness
Watch-outs
- Tirzepatide costs $289 a month, 16% above the $250 median for compounded tirzepatide across the sellers we compare
- Confirm it serves your state before you start the intake
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
Our Verdict
Oak wins this one, 7.8 to 7.1, above all for semaglutide at $119/month, 37% below the typical price. Rehydra+ Wellness fits better if seeing what it charges before you answer any medical questions is your priority.
Choose Oak if…
You want semaglutide at $119/month, 37% below the typical price and an opening price near $119 a month.
Choose Rehydra+ Wellness if…
You want seeing what it charges before you answer any medical questions and an opening price near $119 a month.
Ready to start? GLP-1 providers we have vetted
Telehealth providers, vetted by us, prescribing GLP-1 online.
Vetted by our editors · no insurance required
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Trimi Health
Knowing which pharmacy fills the vial: it names VialsRx
From $99/mo
Get started →ShedRx
Oral orforglipron alongside the injectables
From $149/mo
Get started →bmiMD
Starting below a standard dose, with microdose tiers
From $99/mo
Get started →Oak vs Rehydra+ Wellness: FAQ
Close alternatives to Oak and Rehydra+ Wellness
- Oak vs Trava Health
- Oak vs Belle Health
- Oak vs Fitness RX
- Oak vs Green Cap Health
- Rehydra+ Wellness vs Trava Health
- Rehydra+ Wellness vs Belle Health
Or see the full category ranking.